Related Experiment Video
Updated: Jun 3, 2026
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Symptomatic remission and neurocognitive functioning in patients with schizophrenia
A Hofer1, T Bodner, A Kaufmann
1Medical University Innsbruck, Department of Psychiatry and Psychotherapy, Biological Psychiatry Division, Innsbruck, Austria. alex.hofer@uki.at
Psychological Medicine
|March 24, 2011
Summary
Symptomatic remission and cognitive function, particularly working memory and verbal memory, significantly impact employment outcomes in schizophrenia patients. Further research is needed to understand these long-term associations.
Area of Science:
- Neuroscience
- Psychiatry
- Cognitive Psychology
Background:
- Schizophrenia is a complex mental disorder often associated with cognitive deficits.
- Understanding factors influencing functional outcomes in schizophrenia is crucial for patient care.
Purpose of the Study:
- To investigate the relationship between remission status and neurocognitive functioning in schizophrenia patients.
- To determine the impact of remission and neurocognition on functional outcomes, specifically employment.
Main Methods:
- Cross-sectional study of 140 schizophrenia patients.
- Assessed psychopathological symptoms using the Positive and Negative Syndrome Scale.
- Evaluated neurocognitive domains including attention, executive functioning, verbal fluency, memory, and intelligence.
Main Results:
- 62 out of 140 patients achieved symptomatic remission.
- Remitted patients demonstrated significantly better performance in verbal fluency, alertness, and optical vigilance.
- Symptomatic remission and working/verbal memory performance were significant predictors of employment status.
Conclusions:
- Neuropsychological measures of frontal lobe function correlate with symptomatic remission in schizophrenia.
- Both symptomatic remission and specific cognitive functions (working memory, verbal memory) are key determinants of employment outcomes.
- Longitudinal studies are recommended to explore the dynamic interactions of these factors over time.
Related Concept Videos
01:30Negative and Cognitive Symptoms of Schizophrenia
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:29Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
01:17Schizophrenia
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those diagnosed.
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications